BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16918477)

  • 1. Natural and induced regulatory T cells: targets for immunotherapy of autoimmune disease and allergy.
    Nicolson KS; Wraith DC
    Inflamm Allergy Drug Targets; 2006 Sep; 5(3):141-8. PubMed ID: 16918477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy.
    Verhagen J; Wegner A; Wraith DC
    Immunology; 2015 Jun; 145(2):171-81. PubMed ID: 25716063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+CD25+ regulatory T-cell therapy for allergy, autoimmune disease and transplant rejection.
    Jiang S; Lechler RI
    Inflamm Allergy Drug Targets; 2006 Dec; 5(4):239-42. PubMed ID: 17168794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic peptide vaccines for treatment of autoimmune diseases.
    Wraith DC
    Immunol Lett; 2009 Feb; 122(2):134-6. PubMed ID: 19100774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the mechanisms of oral tolerance and immunotherapy.
    Sosroseno W
    J R Soc Med; 1995 Jan; 88(1):14-7. PubMed ID: 7884761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel therapeutic strategies by regulatory T cells in allergy.
    Elkord E
    Chem Immunol Allergy; 2008; 94():150-157. PubMed ID: 18802345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological mechanisms involved in experimental peptide immunotherapy of T-cell-mediated diseases.
    Wauben MH
    Crit Rev Immunol; 2000; 20(6):451-69. PubMed ID: 11396681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-based immunotherapy: a novel strategy for allergic disease.
    Ali FR; Larché M
    Expert Rev Vaccines; 2005 Dec; 4(6):881-9. PubMed ID: 16372883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell subsets in allergy and tolerance induction.
    Suhrkamp I; Scheffold A; Heine G
    Eur J Immunol; 2023 Oct; 53(10):e2249983. PubMed ID: 37489248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scientific rationale for the Finnish Allergy Programme 2008-2018: emphasis on prevention and endorsing tolerance.
    von Hertzen LC; Savolainen J; Hannuksela M; Klaukka T; Lauerma A; Mäkelä MJ; Pekkanen J; Pietinalho A; Vaarala O; Valovirta E; Vartiainen E; Haahtela T
    Allergy; 2009 May; 64(5):678-701. PubMed ID: 19383025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Treg in immune regulation of allergic diseases.
    Palomares O; Yaman G; Azkur AK; Akkoc T; Akdis M; Akdis CA
    Eur J Immunol; 2010 May; 40(5):1232-40. PubMed ID: 20148422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy.
    Johnson BA; Baban B; Mellor AL
    Immunotherapy; 2009 Jul; 1(4):645-61. PubMed ID: 20161103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic manipulation of immune tolerance in allergic disease.
    Akdis M; Akdis CA
    Nat Rev Drug Discov; 2009 Aug; 8(8):645-60. PubMed ID: 19644474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
    Jutel M; Akdis M; Blaser K; Akdis CA
    Allergy; 2006 Jul; 61(7):796-807. PubMed ID: 16792576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the allergic response by regulatory T cells.
    Stock P; DeKruyff RH; Umetsu DT
    Curr Opin Allergy Clin Immunol; 2006 Feb; 6(1):12-6. PubMed ID: 16505606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antigen-specific unresponsiveness with synthetic peptides: specific immunotherapy for treatment of allergic and autoimmune conditions.
    Wraith DC
    Int Arch Allergy Immunol; 1995 Dec; 108(4):355-9. PubMed ID: 7580308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells: from bench to bedside.
    Jiang S
    Int Immunopharmacol; 2009 May; 9(5):515-7. PubMed ID: 19272465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells as potential immunotherapy in allergy.
    Wing K; Sakaguchi S
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):482-8. PubMed ID: 17088656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
    Coutinho A; Caramalho I; Seixas E; Demengeot J
    Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine tuning subsets of CD4
    Zhao Z; Zhang X; Su L; Xu L; Zheng Y; Sun J
    Int Immunopharmacol; 2018 Mar; 56():269-276. PubMed ID: 29414661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.